logo

For the Inventor, By the Inventor

Guildford, United Kingdom

Reneuron, Inc.


USPTO Granted Patents = 18

% Expired Patents = 44.4



Trademarks = 2

Forward Citations = 141

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal John Sinden (10 out of 10 patents)

silverMedal Wen-Ghih Tsang (5 out of 7 patents)

bronzeMedal Helen Hodges (4 out of 4 patents)

4.  Erik Miljan (3 out of 3 patents)

5.  Kenneth Pollock (3 out of 3 patents)

6.  Paul Stroemer (3 out of 3 patents)

7.  Yanping Wang (2 out of 7 patents)

8.  Caroline Hicks (2 out of 2 patents)

9.  Randolph Corteling (2 out of 2 patents)

10.  Jack Price (2 out of 3 patents)

11.  Paolo Madeddu (2 out of 2 patents)

12.  Tianli Zheng (2 out of 5 patents)

13.  Wei Liu (2 out of 2 patents)

14.  Jinghua Tang (2 out of 2 patents)

15.  Jeffrey A Gray (2 out of 2 patents)


18 patents:

1. 10406182 - Stem cell microparticles and miRNA (2019-09-10),
2. 9745554 - Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture (2017-08-29),
3. 9629879 - Therapeutic use of neural stem cells (2017-04-25),
4. 9410122 - Treatment of limb ischemia (2016-08-09),
5. 9265795 - Cellular compositions for use in therapy (2016-02-23),
6. 9068169 - CD56 positive human adult pancreatic endocrine progenitor cells (2015-06-30),
7. 8932577 - Treatment of limb ischemia (2015-01-13),
8. 8377689 - EPHA4-positive human adult pancreatic endocrine progenitor cells (2013-02-19),
9. 7807459 - EphA4-positive human adult pancreatic endocrine progenitor cells (2010-10-05),
10. 7666672 - Cell lines (2010-02-23),
11. 7419827 - Cell lines (2008-09-02),
12. 7416888 - Cell lines (2008-08-26),
13. 7371576 - CD56 positive human adult pancreatic endocrine progenitor cells (2008-05-13),
14. 7371374 - Neural transplantation using pluripotent neuroepithelial cells (2008-05-13),
15. 7247298 - Treatment of brain damage (2007-07-24),
Company Overview
Reneuron, Inc. is a biotechnology company based in Guildford, UK, specializing in the development of cell-based therapies for neurological conditions and other serious diseases. The company focuses on harnessing the potential of stem cell technology to create innovative treatments aimed at repairing damaged tissues and restoring function. With a commitment to advancing regenerative medicine, Reneuron is at the forefront of research and development in this transformative field, striving to improve patient outcomes through scientific innovation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

18 Patents

#5 in Guildford

#996 in United Kingdom

#34,187 in the World

Guildford, GB
Guildford, United Kingdom

Reneuron, Inc.

Forward Citations = 141

22 inventors:

goldMedal John Sinden (10 out of 10 patents)

silverMedal Wen-Ghih Tsang (5 out of 7 patents)

bronzeMedal Helen Hodges (4 out of 4 patents)

4.  Erik Miljan (3 out of 3 patents)

5.  Kenneth Pollock (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Reneuron, Inc.. Retrieved from https://idiyas.com/company/reneuron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…